{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:32:09Z","timestamp":1769153529275,"version":"3.49.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore the relative factors for best ovarian response in patients undergoing assisted reproductive technology with the gonadotropin-releasing hormone antagonist protocol and to establish a nomogram prediction model of ovarian response.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective cohort analysis of the clinical data of 1,944 patients who received assisted reproductive treatment in the Center for Reproductive Medicine of Fujian Maternity and Child Health Hospital from April 1, 2018, to June 30, 2020. According to the number of oocytes obtained, there were 659 cases in the low ovarian response group (no more than five oocytes were retrieved), 920 cases in the normal ovarian response group (the number of retrieved oocytes was &amp;gt;5 but \u226418), and 365 cases in the high ovarian response group (&amp;gt;18 oocytes retrieved). Independent factors affecting ovarian responsiveness were screened by logistic regression, which were the model entry variables, and a nomogram prediction model was established based on the regression coefficients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were statistically significant differences in age, anti-Mullerian hormone, antral follicle count, the diagnosis of endometriosis, decreased ovarian reserve, polycystic ovary syndrome, basal follicle-stimulating hormone and basal luteinizing hormone among the three groups (P &amp;lt; 0.001). Multifactorial stepwise regression analysis showed that female age (0.95 [0.92\u20130.97], <jats:italic>P<\/jats:italic> = 0.000), decreased ovarian reserve (0.27 [0.19-0.38]), <jats:italic>P<\/jats:italic> = 0.000), endometriosis (0.81 [0.56-0.86], <jats:italic>P<\/jats:italic> = 0.000), antral follicle count (1.09 [1.06-1.12], <jats:italic>P<\/jats:italic> = 0.000), basal follicle-stimulating hormone (0.90 [0.85-0.96], <jats:italic>P<\/jats:italic> = 0.001), Anti-Mullerian hormone (1.19 [1.13\u20131.26], <jats:italic>P<\/jats:italic>= 0.000) and luteinizing hormone on trigger day (0.73 [0.66\u20130.80], <jats:italic>P<\/jats:italic>= 0.000), were independent factors for the occurrence of different ovarian responses during ovarian hyperstimulation. The predictive model of ovarian responsiveness was constructed based on the above factors, and the model was verified with 589 patients\u2019 data from July 1, 2020, to December 31, 2020, at this center. The predicted ovarian response (number of eggs obtained) of a total of 450 patients was consistent with the actual results, with a coincidence degree of 76.4%, and the consistency index of the model is 0.77.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The nomogram model was successfully developed to effectively, intuitively, and visually predict the ovary reactivity in the gonadotropin-releasing hormone antagonist protocol and provide guidance for clinical practice.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1030201","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T07:51:31Z","timestamp":1668498691000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of relative factors and prediction model for optimal ovarian response with gonadotropin-releasing hormone antagonist protocol"],"prefix":"10.3389","volume":"13","author":[{"given":"Wenwen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beihong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuhua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suqin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huale","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s1472-6483(10)60859-0","article-title":"Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility","volume":"12","author":"van Rooij","year":"2006","journal-title":"Reprod BioMed Online."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.10.047","article-title":"Racial and ethnic differences in reproductive potential across the life cycle","volume":"93","author":"Butts","year":"2010","journal-title":"Fertil Steril."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew358","article-title":"Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: Secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols","volume":"32","author":"Toftager","year":"2017","journal-title":"Hum Reprod"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: A prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Hum Reprod"},{"key":"B5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3978\/j.issn.2305-5839.2015.04.09","article-title":"Comparison of different stimulation protocols used in in vitro fertilization: A review","volume":"3","author":"Shrestha","year":"2015","journal-title":"Ann Transl Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.09.020","article-title":"Quality of life and psychosocial and physical well-being among 1,023 women during their first assisted reproductive technology treatment: Secondary outcome to a randomized controlled trial comparing gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist protocols","volume":"109","author":"Toftager","year":"2018","journal-title":"Fertil Steril."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.29252\/ijrm.16.3.175","article-title":"Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: An RCT","volume":"16","author":"Depalo","year":"2018","journal-title":"Int J Reprod Biomed"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: From theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey244","article-title":"Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF","volume":"33","author":"Fabregues","year":"2018","journal-title":"Hum Reprod"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4784.17.04044-8","article-title":"Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers","author":"Grisendi","year":"2017","journal-title":"Minerva Ginecol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12978-015-0053-4","article-title":"Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation","volume":"12","author":"Aghssa","year":"2015","journal-title":"Reprod Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12958-015-0113-1","article-title":"Predictive factors for ovarian response in a corifollitropin alfa\/GnRH antagonist protocol for controlled ovarian stimulation in IVF\/ICSI cycles","volume":"13","author":"Oehninger","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des389","article-title":"High ovarian response does not jeopardize ongoing pregnancy ratesand increases cumulative pregnancy rates in a GnRH-antagonist protocol","volume":"28","author":"Human","year":"2013","journal-title":"Hum Reprod"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-11-20","article-title":"Optimal usage of the GnRH antagonists: A review of the literature","volume":"11","author":"Copperman","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der392","article-title":"Nomogram to predict pregnancy rate after ICSI-IVF cycle in patients with endometriosis","volume":"27","author":"Ballester","year":"2012","journal-title":"Hum Reprod"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012103.pub2","article-title":"Interventions for the prevention of OHSS in ART cycles: An overview of cochrane reviews","volume":"1","author":"Mourad","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2019.05.018","article-title":"Ovarian hyperstimulation syndrome: A review for emergency clinicians","volume":"37","author":"Timmons","year":"2019","journal-title":"Am J Emerg Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112141-20220501-00287","article-title":"Clinical characteristics of severe late-onset ovarian hyperstimulation syndrome and its impact on the live birth outcome of IVF-ET","author":"Ma","year":"2022","journal-title":"Zhonghua Fu Chan Ke Za Zhi."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.08.048","article-title":"Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline","volume":"106","year":"2016","journal-title":"Fertil Steril"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.02.001","article-title":"Cumulative live birth rates in more than 3,000 patients with poor ovarian response: a 15-year survey of final in vitro fertilization outcome","volume":"109","author":"Xu","year":"2018","journal-title":"Fertil Steril."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2016.02.013","article-title":"Younger poor ovarian response women achieved better pregnancy results in the first three IVF cycles","volume":"32","author":"Yang","year":"2016","journal-title":"Reprod BioMed Online."},{"key":"B22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/humupd\/dmu062","article-title":"Technical and performance characteristics of anti-m\u00fcllerian hormone and antral follicle count as biomarkers of ovarian response","volume":"21","author":"Iliodromiti","year":"2015","journal-title":"Hum Reprod Update."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1093\/humrep\/dew149","article-title":"Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials","author":"Humaidan","year":"2016","journal-title":"Hum Reprod"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-5-9","article-title":"Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization","volume":"5","author":"Kwee","year":"2007","journal-title":"Reprod Biol Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5246217","article-title":"Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: Prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil Steril"},{"key":"B26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(02)04562-4","article-title":"Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization","volume":"79","author":"Chuang","year":"2003","journal-title":"Fertil Steril."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5246217","DOI":"10.1155\/2016\/5246217","article-title":"Anti-mullerian hormone: Above and beyond conventional ovarian reserve markers","author":"Jamil","year":"2016","journal-title":"Dis Markers."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1030201\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T07:51:37Z","timestamp":1668498697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1030201\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":28,"alternative-id":["10.3389\/fendo.2022.1030201"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1030201","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"article-number":"1030201"}}